Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Influenza

Free Subscription Articles published in J Exp Med Retrieve available abstracts of 21 articles: HTML format

Single Articles

July 2025
1. SAIDOUNE F, Lee D, Di Domizio J, Le Floc'h C, et al
   Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains.
   J Exp Med. 2025;222:e20231467.
   PubMed     Abstract available
   
   
   
2. MATZ HC, Ellebedy AH
   Vaccination against influenza viruses annually: Renewing or narrowing the protective shield?
   J Exp Med. 2025;222:e20241283.
   PubMed     Abstract available
   
   
   June 2025
3. GROEN K, Kuratli R, Enkelmann J, Fernbach S, et al
   Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.
   J Exp Med. 2025;222:e20242039.
   PubMed     Abstract available
   
   
   
4. MADSEN A, Okba NMA, Pholcharee T, Matz HC, et al
   Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody.
   J Exp Med. 2025;222:e20241930.
   PubMed     Abstract available
   
   
   January 2025
5. VALERI E, Kajaste-Rudnitski A
   Antiviral immunity lassoed down by excess RNA.
   J Exp Med. 2025;222:e20241743.
   PubMed     Abstract available
   
   
   December 2024
6. BELLOS E, Santillo D, Vantourout P, Jackson HR, et al
   Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C).
   J Exp Med. 2024;221:e920240699.
   PubMed     Abstract available
   
   
   October 2024
7. JEGER-MADIOT R, Planas D, Staropoli I, Debarnot H, et al
   Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting.
   J Exp Med. 2024;221:e20240289.
   PubMed     Abstract available
   
   
   September 2024
8. ZANONI I
   Kids' noses resist COVID-19.
   J Exp Med. 2024;221:e20241027.
   PubMed     Abstract available
   
   
   
9. WATKINS TA, Green AB, Amat JAR, Cheemarla NR, et al
   High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children.
   J Exp Med. 2024;221:e20230911.
   PubMed     Abstract available
   
   
   
10. CHAN YH, Lundberg V, Le Pen J, Yuan J, et al
    SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency.
    J Exp Med. 2024;221:e20231725.
    PubMed     Abstract available
    
    
    
11. FERNBACH S, Mair NK, Abela IA, Groen K, et al
    Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
    J Exp Med. 2024;221:e20240365.
    PubMed     Abstract available
    
    
    August 2024
12. MCINTIRE KM, Meng H, Lin TH, Kim W, et al
    Maturation of germinal center B cells after influenza virus vaccination in humans.
    J Exp Med. 2024;221:e20240668.
    PubMed     Abstract available
    
    
    July 2024
13. MACLEAN AJ, Bonifacio JPPL, Oram SL, Mohsen MO, et al
    Regulation of pulmonary plasma cell responses during secondary infection with influenza virus.
    J Exp Med. 2024;221:e20232014.
    PubMed     Abstract available
    
    
    June 2024
14. WU TT, Travaglini KJ, Rustagi A, Xu D, et al
    Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung.
    J Exp Med. 2024;221:e20232192.
    PubMed     Abstract available
    
    
    February 2024
15. BASTARD P, Gervais A, Taniguchi M, Saare L, et al
    Higher COVID-19 pneumonia risk associated with anti-IFN-alpha than with anti-IFN-omega auto-Abs in children.
    J Exp Med. 2024;221:e20231353.
    PubMed     Abstract available
    
    
    November 2023
16. RUTERBUSCH MJ, Hondowicz BD, Takehara KK, Pruner KB, et al
    Allergen exposure functionally alters influenza-specific CD4+ Th1 memory cells in the lung.
    J Exp Med. 2023;220:e20230112.
    PubMed     Abstract available
    
    
    September 2023
17. WANG Z, Muecksch F, Raspe R, Johannsen F, et al
    Memory B cell development elicited by mRNA booster vaccinations in the elderly.
    J Exp Med. 2023;220:e20230668.
    PubMed     Abstract available
    
    
    August 2023
18. RYBKINA K, Bell JN, Bradley MC, Wohlbold T, et al
    SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19.
    J Exp Med. 2023;220:e20221518.
    PubMed     Abstract available
    
    
    
19. LIN YS, Chang YC, Chao TL, Tsai YM, et al
    The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage.
    J Exp Med. 2023;220:e20220727.
    PubMed     Abstract available
    
    
    
20. GILBERTSON B, Subbarao K
    Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential.
    J Exp Med. 2023;220:e20230447.
    PubMed     Abstract available
    
    
    May 2023
21. GARCIA-GARCIA A, Perez de Diego R, Flores C, Rinchai D, et al
    Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia.
    J Exp Med. 2023;220:e20220170.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.